Cargando…
Hypothesis: Amelioration of obesity‐induced cognitive dysfunction via a lorcaserin–betahistine combination treatment
The prolonged exposure to obesogenic diets disrupts the mesocortical dopaminergic input to the prefrontal cortex (PFC). This leads to suboptimal dopamine levels in this brain region, which affects cognition and control of food intake. Treatments that restore mesocortical dopaminergic neurotransmissi...
Autores principales: | dela Peña, Ike C., Figueroa, Johnny D., Shi, Wei‐Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124816/ https://www.ncbi.nlm.nih.gov/pubmed/35599337 http://dx.doi.org/10.1002/prp2.947 |
Ejemplares similares
-
Lorcaserin for weight management
por: Taylor, James R, et al.
Publicado: (2013) -
The use of lorcaserin in the management of obesity: a critical appraisal
por: Bai, Bo, et al.
Publicado: (2010) -
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
por: Hurt, Ryan T, et al.
Publicado: (2018) -
Lorcaserin for the treatment of obesity? A closer look at its side effects
por: DiNicolantonio, James J, et al.
Publicado: (2014) -
Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
por: Song, Eun-Ji, et al.
Publicado: (2023)